Talk:Carbapenem-resistant enterobacteriaceae

CRE Talk

The original version was fairly speculative. Carbapenems are not necessarily the last line of defence. They tend to be broadly effective. 17:20, 30 November 2012‎ 208.25.211.33 (talk)‎

I am hoping to extend the scope of the page and bring in high quality references. I am hoping to do this as a project with my 100 microbiology students at the College of William and Mary this week. I realize this may be a bit messy but they have already come up with some amazing articles and data sources to improve the page. Topics on which we have found primary or review papers include: 1) What is the mechanism of carbapentem antibiotics? 2) What is mechanism of carbapentem resistance? 3) What is mechanism of transfer of carbapentem resistance to other bacteria? 4) Paper on method of detection/monitoring of carbapentem resistance bacteria in hospitals. 5) Survival rates of carbapentem resistant infection. 6) Paper on methods for reducing transmission of multidrug resistant bacteria in hospital settings. 7) Paper describing a drug trial of carbapentem antibiotics. 8) Paper describing CRE outbreak or transmission in the hospital setting. 9) Animals as source of multi-drug resistant bacteria. Catherine Koebel (talk) 15:57, 22 April 2013 (UTC)

We are beginning our edits today Catherine Koebel (talk) 13:26, 23 April 2013 (UTC)

CPE

CRE have been called CPE (Carbapenamase-Producing Enterobacteriaceae), at least in one Medscape publication.

Maybe we should consider adding CPE as an alternative title, or at least a redirection page? — Preceding unsigned comment added by AbderrahmanNajjar (talk • contribs) 08:32, 7 August 2013 (UTC)

Los Angeles 'incident'

This may be of interest if there are any fatalities. "Nearly 180 people at a Los Angeles hospital may have been exposed to'nightmare' strain of bacteria from the use of contaminated medical equipment." Los Angeles superbug CRE: What is the drug-resistant 'nightmare' family of bacteria? 220 of ^Borg 00:48, 20 February 2015 (UTC)

220 of Borg, it was already in the article under #Risk of Transmission when you wrote this. --Wuerzele (talk) 21:33, 22 February 2015 (UTC)

Whoops! Thanks for letting me know.220 of ^Borg 14:50, 23 February 2015 (UTC)

recent CRE edits

Doc James made sweeping edits, most without edit summary. I reverted ONE . He re-reverted, speak is edit warring Per WP:BRD it is his turn to discuss, here. This continuously arrogant behavior( no edit summary, re-reverting without discussion is very uncivil.--Wuerzele (talk) 03:53, 28 February 2015 (UTC)

Ah, I thought you were just reverting because you didn't like the lack of an edit summary for the edit in question.

I changed the heading from "Laboratory analysis" to "Diagnosis" as the later is simplier and the recommended heading by WP:MEDMOS per the second edit summary. Doc James (talk · contribs · email) 03:59, 28 February 2015 (UTC)

Ah, and I though you had a real reason. Simplier? what about accuracy? Diagnosis of carbapenem resistance is not your field. you just come here no edit summaries , monarchial and think yo can change what you want . I still do not see what all you removed and why. ever thought about communictaing with thos ethat edit a site, I mean really edit? you didnt do it at antibiotic resistance, not in 2013 and not in 2015. Its your way or the highway. And ping me , I ve said this about 3 times, you just seem not to remember these little things!--Wuerzele (talk) 06:39, 2 March 2015 (UTC)

Yes diagnosis is simplier. Why ping you? You obviously have this page watched. Doc James (talk · contribs · email) 07:03, 2 March 2015 (UTC)